Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.46 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4599785 | 0.83 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP2C9CYP2C19NPSR1 | |
| SCHEMBL29545673 | 0.82 | CYP4F2 (0.42) | CYP1A2CYP2D6CYP2C9CYP2C19NPSR1 | |
| SCHEMBL509144 | 0.82 | CYP4F2 (0.42) | CYP1A2CYP2D6CYP2C9CYP2C19NPSR1 | |
| SCHEMBL30531106 | 0.79 | CYP1A2 (0.50) | CYP1A2CYP2D6CYP2C9CYP2C19NPSR1 | |
| SCHEMBL25359980 | 0.79 | CYP1A2 (0.50) | CYP1A2CYP2D6CYP2C9CYP2C19NPSR1 | |
| SCHEMBL29418197 | 0.79 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP2C9CYP2C19NPSR1 | |
| SCHEMBL11244115 | 0.79 | KDM4E (0.49) | CYP1A2CYP2D6CYP2C9CYP2C19NPSR1 | |
| SCHEMBL333551 | 0.79 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP2C9CYP2C19NPSR1 | |
| SCHEMBL93021 | 0.78 | CYP4F2 (0.50) | CYP4F2CYP4A11KIF11MAOAMAOB | |
| SCHEMBL29875658 | 0.78 | CA2 (0.38) | CYP1A2CYP2D6CYP2C9CYP2C19NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118439937-A | Synthetic method of 4-fluoro-3-phenoxybenzaldehyde serving as key intermediate of insect repellent | 康龙化成(绍兴)药业有限公司 | 2024-08-06 | — | — | CN | claimed |
| EP-0024612-B1 | NEW 4-FLUORO-3-PHENOXY-BENZYL-ETHERS, PROCESS FOR THEIR PREPARATION AND THEIR USE | BAYER AG (DE) | 1983-10-05 | — | — | EP | claimed |
| EP-0059365-A2 | 3-Bromo-4-fluoro-benzyl derivatives, and methods for their preparation | BAYER AG (DE) | 1982-09-08 | — | — | EP | claimed |
| US-4326087-A | REACTING 3-BROMO-4-FLUORO-BENZYL ALCOHOL WITH A CHLORINATING OR BROMINATING AGENT OR 3-BROMO-4-FLUORO-BENZOYL FLUORIDE WITH A HYDRIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1982-04-20 | — | — | US | claimed |
| EP-0048914-A1 | Process for the preparation of 3-bromo-4-fluorobenzyl alcohol, intermediate products therefor, and process for the preparation of these intermediate products | BAYER AG (DE) | 1982-04-07 | — | — | EP | claimed |
| EP-0024612-A2 | New 4-fluoro-3-phenoxy-benzyl-ethers, process for their preparation and their use | BAYER AG (DE) | 1981-03-11 | — | — | EP | claimed |
| US-20250197368-A1 | 2-OXO-DIHYDROQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS GABA TYPE A RECEPTOR MODULATORS | DRAIG THERAPEUTICS LTD. (GB) | 2025-06-19 | — | — | US | disclosed |
| CN-118439937-A | Synthetic method of 4-fluoro-3-phenoxybenzaldehyde serving as key intermediate of insect repellent | 康龙化成(绍兴)药业有限公司 | 2024-08-06 | — | — | CN | disclosed |
| EP-4228761-A1 | 2-OXO-DIHYDROQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS GABA TYPE A RECEPTOR MODULATORS | University College Cardiff Consultants Limited (GB) | 2023-08-23 | — | — | EP | disclosed |
| CN-116472042-A | 2-oxo-dihydroquinoline-3-carboxamide derivatives as modulators of GABA A type receptors | 加的夫大学学院咨询有限公司 | 2023-07-21 | — | — | CN | disclosed |
| US-11560389-B2 | Heterocyclic inhibitors of monocarboxylate transporters | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-01-24 | — | — | US | disclosed |
| CN-110325531-B | Benzenesulfonamides and their use as therapeutic agents | 泽农医药公司 | 2022-05-27 | — | — | CN | disclosed |
| WO-2022079432-A1 | 2-OXO-DIHYDROQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS GABA TYPE A RECEPTOR MODULATORS | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2022-04-21 | — | — | WO | disclosed |
| EP-0059365-A2 | 3-Bromo-4-fluoro-benzyl derivatives, and methods for their preparation | BAYER AG (DE) | 1982-09-08 | — | — | EP | disclosed |
| US-4326087-A | REACTING 3-BROMO-4-FLUORO-BENZYL ALCOHOL WITH A CHLORINATING OR BROMINATING AGENT OR 3-BROMO-4-FLUORO-BENZOYL FLUORIDE WITH A HYDRIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1982-04-20 | — | — | US | disclosed |
| EP-0048914-A1 | Process for the preparation of 3-bromo-4-fluorobenzyl alcohol, intermediate products therefor, and process for the preparation of these intermediate products | BAYER AG (DE) | 1982-04-07 | — | — | EP | disclosed |
| EP-0048914-A1 | Process for the preparation of 3-bromo-4-fluorobenzyl alcohol, intermediate products therefor, and process for the preparation of these intermediate products | BAYER AG (DE) | 1982-04-07 | — | — | EP | disclosed |
| EP-0048914-A1 | Process for the preparation of 3-bromo-4-fluorobenzyl alcohol, intermediate products therefor, and process for the preparation of these intermediate products | BAYER AG (DE) | 1982-04-07 | — | — | EP | disclosed |
| EP-0024612-A2 | New 4-fluoro-3-phenoxy-benzyl-ethers, process for their preparation and their use | BAYER AG (DE) | 1981-03-11 | — | — | EP | disclosed |
| EP-0024624-A2 | 4-Fluoro-3-phenoxy-benzaldehyde acetals, process for their preparation and intermediate products therefor | BAYER AG (DE) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11560389-B2 | Heterocyclic inhibitors of monocarboxylate transporters | SLC16A1, SLC16A3, SLC16A7 | CYP1A2 1205/4885CYP2D6 1231/4885CYP2C9 1146/4885 |
| US-20250197368-A1 | 2-OXO-DIHYDROQUINOLINE-3-CARBOXAMIDE DERIVATIVES AS GABA TYPE A RECEPTOR MODULATORS | GABRA2, GABRA3, GABRB2 | CYP1A2 181/4885CYP2D6 618/4885CYP2C9 834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.